Thermo Fisher Scientific Inc.

NYSE:TMO Stock Report

Market Cap: US$215.8b

Thermo Fisher Scientific Future Growth

Future criteria checks 1/6

Thermo Fisher Scientific is forecast to grow earnings and revenue by 10.6% and 5% per annum respectively. EPS is expected to grow by 11.6% per annum. Return on equity is forecast to be 19.9% in 3 years.

Key information

10.6%

Earnings growth rate

11.6%

EPS growth rate

Life Sciences earnings growth16.2%
Revenue growth rate5.0%
Future return on equity19.9%
Analyst coverage

Good

Last updated12 Apr 2024

Recent future growth updates

Here's What Analysts Are Forecasting For Thermo Fisher Scientific Inc. (NYSE:TMO) After Its Yearly Results

Feb 02
Here's What Analysts Are Forecasting For Thermo Fisher Scientific Inc. (NYSE:TMO) After Its Yearly Results

Recent updates

Investors Still Waiting For A Pull Back In Thermo Fisher Scientific Inc. (NYSE:TMO)

Apr 02
Investors Still Waiting For A Pull Back In Thermo Fisher Scientific Inc. (NYSE:TMO)

We Think Thermo Fisher Scientific (NYSE:TMO) Can Stay On Top Of Its Debt

Mar 12
We Think Thermo Fisher Scientific (NYSE:TMO) Can Stay On Top Of Its Debt

Thermo Fisher's Bright Future Makes It A Great Buy On Weakness

Feb 06

Here's What Analysts Are Forecasting For Thermo Fisher Scientific Inc. (NYSE:TMO) After Its Yearly Results

Feb 02
Here's What Analysts Are Forecasting For Thermo Fisher Scientific Inc. (NYSE:TMO) After Its Yearly Results

Thermo Fisher: Blue Chip Stock Melded With Growth Characteristics

Jan 16

Thermo Fisher: Downturn In Pharma And Biotech And Weak China Growth; Initiate With 'Hold'

Jan 06

Is Now An Opportune Moment To Examine Thermo Fisher Scientific Inc. (NYSE:TMO)?

Dec 29
Is Now An Opportune Moment To Examine Thermo Fisher Scientific Inc. (NYSE:TMO)?

Does Thermo Fisher Scientific (NYSE:TMO) Have A Healthy Balance Sheet?

Dec 11
Does Thermo Fisher Scientific (NYSE:TMO) Have A Healthy Balance Sheet?

Thermo Fisher Scientific: I Am Still Waiting For An Attractive Buying Opportunity.

Dec 02

Thermo Fisher Scientific Inc. (NYSE:TMO) Shares Could Be 25% Below Their Intrinsic Value Estimate

Nov 07
Thermo Fisher Scientific Inc. (NYSE:TMO) Shares Could Be 25% Below Their Intrinsic Value Estimate

My Family Is Buying A Lot More Thermo Fisher Stock

Oct 31

Thermo Fisher: An Up To 35% Undervalued Healthcare Gem I Like On Weakness

Sep 28

Is Thermo Fisher Scientific (NYSE:TMO) A Risky Investment?

Sep 10
Is Thermo Fisher Scientific (NYSE:TMO) A Risky Investment?

Thermo Fisher Scientific: A High-Quality Investment For Double-Digit Returns

Aug 28

Thermo Fisher: Cash Flow Returns On Investments Analysis

Aug 14

Calculating The Fair Value Of Thermo Fisher Scientific Inc. (NYSE:TMO)

Jul 25
Calculating The Fair Value Of Thermo Fisher Scientific Inc. (NYSE:TMO)

Thermo Fisher Scientific: Continuing To Add To The Fortress

Jul 09

Thermo Fisher: A Master Compounder In Healthcare

Jul 03

These 4 Measures Indicate That Thermo Fisher Scientific (NYSE:TMO) Is Using Debt Reasonably Well

Jun 07
These 4 Measures Indicate That Thermo Fisher Scientific (NYSE:TMO) Is Using Debt Reasonably Well

Buy Thermo Fisher, But With Caution

Jun 01

Thermo Fisher Scientific Inc.'s (NYSE:TMO) Intrinsic Value Is Potentially 25% Below Its Share Price

Apr 26
Thermo Fisher Scientific Inc.'s (NYSE:TMO) Intrinsic Value Is Potentially 25% Below Its Share Price

Earnings and Revenue Growth Forecasts

NYSE:TMO - Analysts future estimates and past financials data (USD Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/202649,3788,1718,75110,48416
12/31/202546,0327,0567,9109,29825
12/31/202443,0166,3437,3218,72625
12/31/202342,8575,9956,9278,406N/A
9/30/202343,4215,9416,5468,170N/A
7/1/202343,5245,7215,8547,693N/A
4/1/202343,8076,0245,6207,681N/A
12/31/202244,9156,9506,9119,154N/A
10/1/202244,1677,0325,6008,124N/A
7/2/202242,8207,4396,3368,837N/A
4/2/202241,1237,6037,0019,536N/A
12/31/202139,2117,7256,7899,312N/A
10/2/202139,0598,5657,91610,194N/A
7/3/202138,2508,5968,13210,252N/A
4/3/202135,8947,9248,0629,911N/A
12/31/202032,2186,3756,8158,289N/A
9/26/202028,4974,8795,6866,863N/A
6/27/202026,2483,7064,2455,272N/A
3/28/202025,6473,6693,7024,680N/A
12/31/201925,5423,6964,0474,973N/A
9/28/201925,2203,5923,9404,861N/A
6/29/201924,8683,5414,0864,964N/A
3/30/201924,6303,1744,2735,114N/A
12/31/201824,3582,9383,7854,543N/A
9/29/201823,8982,5703,9194,608N/A
6/30/201823,0942,3953,6894,317N/A
3/31/201822,0062,2563,1893,722N/A
12/31/201720,9182,2283,4974,005N/A
9/30/201719,8242,330N/A3,344N/A
7/1/201719,1992,270N/A3,220N/A
4/1/201718,7442,174N/A3,284N/A
12/31/201618,2742,025N/A3,258N/A
10/1/201617,9731,999N/A3,281N/A
7/2/201617,6062,003N/A3,220N/A
4/2/201617,3411,998N/A3,072N/A
12/31/201516,9651,980N/A2,942N/A
9/26/201516,8061,978N/A2,543N/A
6/27/201516,8541,971N/A2,475N/A
3/28/201516,9051,738N/A2,598N/A
12/31/201416,8901,896N/A2,620N/A
9/27/201415,8641,635N/A2,394N/A
6/28/201414,8841,482N/A2,224N/A
3/29/201413,8021,481N/A1,814N/A
12/31/201313,0901,279N/A2,011N/A
9/28/201312,8831,322N/A1,942N/A
6/29/201312,7771,304N/A1,917N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: TMO's forecast earnings growth (10.6% per year) is above the savings rate (2.3%).

Earnings vs Market: TMO's earnings (10.6% per year) are forecast to grow slower than the US market (14.7% per year).

High Growth Earnings: TMO's earnings are forecast to grow, but not significantly.

Revenue vs Market: TMO's revenue (5% per year) is forecast to grow slower than the US market (8.1% per year).

High Growth Revenue: TMO's revenue (5% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: TMO's Return on Equity is forecast to be low in 3 years time (19.9%).


Discover growth companies

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.